Marirosa Mora

Rafael Advanced Defense Systems (Israel) — Israel

Medicine · Health Sciences

26h-index8.6kcitations42works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Streptococcal Infections and Treatments(17), Neonatal and Maternal Infections(14), Bacterial Infections and Vaccines(13), Pneumonia and Respiratory Infections(11), Antimicrobial Resistance in Staphylococcus(5)

Publications42 total

Vacunación de pacientes adultos receptores de trasplante de células madre hematopoyéticas: Perspectiva de Costa Rica
Revista chilena de infectología·2016· 2 citedOpen Access
The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles
Molecular & Cellular Proteomics·2015· 57 citedOpen Access
SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains
PLoS Pathogens·2014· 65 citedOpen Access
Neisseria Adhesin A Variation and Revised Nomenclature Scheme
Clinical and Vaccine Immunology·2014· 56 citedOpen Access
SpyAD, a Moonlighting Protein of Group A Streptococcus Contributing to Bacterial Division and Host Cell Adhesion
Infection and Immunity·2014· 28 citedOpen Access
Conservation of Meningococcal Antigens in the Genus <i>Neisseria</i>
mBio·2013· 55 citedOpen Access
Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case
Molecular & Cellular Proteomics·2012· 135 citedOpen Access
Genome-based approaches to vaccine development
Journal of Molecular Medicine·2010· 24 citedOpen Access
Protein Array Profiling of Tic Patient Sera Reveals a Broad Range and Enhanced Immune Response against Group A Streptococcus Antigens
PLoS ONE·2009· 71 citedOpen Access
Surfome Analysis as a Fast Track to Vaccine Discovery
Molecular & Cellular Proteomics·2009· 97 citedOpen Access
Genome-Based Vaccine Development: A Short Cut for the Future
Advances in experimental medicine and biology·2009· 6 cited
Preventing Bacterial Infections with Pilus-Based Vaccines: the Group B Streptococcus Paradigm
The Journal of Infectious Diseases·2008· 230 citedOpen Access
Sequence Variation in Group A<i>Streptococcus</i>Pili and Association of Pilus Backbone Types with Lancefield T Serotypes
The Journal of Infectious Diseases·2008· 128 cited
Genome‑based vaccine development: A short cut for the future
Human Vaccines·2008· 43 cited
<i>Streptococcus pyogenes</i> pili promote pharyngeal cell adhesion and biofilm formation
Molecular Microbiology·2007· 245 citedOpen Access
Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach
Current Opinion in Microbiology·2006· 92 cited
Identification of novel genomic islands coding for antigenic pilus‐like structures in <i>Streptococcus agalactiae</i>
Molecular Microbiology·2006· 242 citedOpen Access
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome
Nature Biotechnology·2006· 428 cited
Group A <i>Streptococcus</i> produce pilus-like structures containing protective antigens and Lancefield T antigens
Proceedings of the National Academy of Sciences·2005· 394 citedOpen Access
Genome analysis of multiple pathogenic isolates of <i>Streptococcus agalactiae</i> : Implications for the microbial “pan-genome”
Proceedings of the National Academy of Sciences·2005· 2.6k citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Guido Grandi(16), Rino Rappuoli(15), John L. Telford(13), Immaculada Margarit(12), Maria Scarselli(10), Vega Masignani(9), Mara Rossini(9), Giuliano Bensi(8), Lubbertus C. F. Mulder(8), Massimo Lazzeri(8), Paolo Bruzzone(8), Mariagrazia Pizza(7), D Alfani(7), Domenico Maione(6), Roberto Rosini(6), Sandra Nuti(5), C. Daniela Rinaudo(5), Sabrina Capo(5), Fabiana Falugi(5), Andrea G. O. Manetti(5)